HALO logo
halo search icon
Q32 Bio Inc

US$5.67

Price Change Indicator
-0.40 (-6.59%)
Q32 Bio Inc
QTTB · NAS

Q32 Bio Inc

Start Trading QTTB for Free

US$5.67

Price Arrow-0.40 (-6.59%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHALO Earnings MomentumHALO MomentumHALO Price Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Q32 Bio Inc Overview

QTTB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About QTTB

icon
icon

Telephone

icon

Address

2nd floor, 830 Winter Street, Waltham, MA 02451

Description

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

QTTB Price Chart

Key Stats

Market Cap

US$102.93M

PE

1.40

EV/EBITDA

0.1

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.35 - 8.05

Trade Value (12mth)

US$1,115,244.00

1 week

-3.65%

1 month

-5.45%

YTD

76.45%

1 year

265.66%

All time high

572.40

Key Fundamentals

EPS 3 yr Growth

-254.50%

EBITDA Margin

32.20%

Operating Cashflow

-$34m

Free Cash Flow Return

-94.10%

ROIC

83.70%

Interest Coverage

15.70

Quick Ratio

4.90

Other Data

Shares Outstanding (Fully Diluted)

14m

HALO Sector

Healthcare

Next Company Report Date

16-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

QTTB Announcements

Latest Announcements

DateAnnouncements
05 May 26
05 May 26
05 May 26
05 May 26
05 May 26

QTTB Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-153.97-5.122.42locklocklock
EPS (Fully Diluted)
 $locklocklocklock-153.97-6.582.42locklocklock
Growth
 %locklocklocklock-9,709.396.7147.3locklocklock
PE
 XlocklocklocklockN/AN/A1.4locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/A0.1locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Q32 Bio Inc (QTTB:NAS)?
Halo FAQ
The current share price of Q32 Bio Inc (QTTB:NAS) is USD$5.67.
What is the 52-week high share price for Q32 Bio Inc (QTTB:NAS)?
Halo FAQ
The 52-week high share price for Q32 Bio Inc (QTTB:NAS) is USD$8.05.
What is the 52-week low share price for Q32 Bio Inc (QTTB:NAS)?
Halo FAQ
The 52-week low share price for Q32 Bio Inc (QTTB:NAS) is USD$1.35.
What is the dividend yield for Q32 Bio Inc (QTTB:NAS)?
Halo FAQ
Q32 Bio Inc (QTTB:NAS) does not pay a dividend.
What was Q32 Bio Inc (QTTB:NAS) last dividend payment?
Halo FAQ
Q32 Bio Inc (QTTB:NAS) does not pay a dividend.
What is the franking level for Q32 Bio Inc (QTTB:NAS)?
Halo FAQ
Q32 Bio Inc (QTTB:NAS) has a franking level of 0.00%.
In which sector is Q32 Bio Inc (QTTB:NAS) classified?
Halo FAQ
Q32 Bio Inc (QTTB:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Q32 Bio Inc (QTTB:NAS)?
Halo FAQ
The current P/E ratio for Q32 Bio Inc (QTTB:NAS) is 1.40.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial